THE BioMed Co., Ltd. (KOSDAQ:214610)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,970.00
-330.00 (-7.67%)
At close: Oct 10, 2025

THE BioMed Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
33,25460,85380,68187,860166,501204,207
Upgrade
Market Cap Growth
-57.40%-24.58%-8.17%-47.23%-18.46%148.32%
Upgrade
Enterprise Value
40,37473,659100,38997,164156,031213,436
Upgrade
Last Close Price
3970.0013970.0018520.0030812.1658414.7372216.01
Upgrade
PS Ratio
19.4113.1215.035.455.504.47
Upgrade
PB Ratio
1.762.352.224.983.193.65
Upgrade
P/TBV Ratio
1.773.142.615.323.273.71
Upgrade
EV/Sales Ratio
23.5715.8718.706.035.154.67
Upgrade
EV/EBITDA Ratio
-----40.72
Upgrade
EV/EBIT Ratio
-----61.59
Upgrade
Debt / Equity Ratio
0.390.830.381.320.420.12
Upgrade
Debt / EBITDA Ratio
-----1.28
Upgrade
Asset Turnover
0.050.080.090.220.380.95
Upgrade
Inventory Turnover
0.561.170.850.920.822.03
Upgrade
Quick Ratio
0.101.091.420.574.023.93
Upgrade
Current Ratio
0.741.892.701.335.946.46
Upgrade
Return on Equity (ROE)
-102.27%-90.33%-95.59%-111.40%-19.57%-20.29%
Upgrade
Return on Assets (ROA)
-23.73%-23.72%-21.02%-22.17%-8.50%4.51%
Upgrade
Return on Capital (ROIC)
-28.02%-28.23%-27.48%-28.10%-9.90%5.24%
Upgrade
Return on Capital Employed (ROCE)
-----5.60%
Upgrade
Earnings Yield
-74.24%-50.69%-31.95%-44.27%-6.35%-2.83%
Upgrade
FCF Yield
-47.12%-19.15%-14.56%-17.79%-6.87%-11.97%
Upgrade
Buyback Yield / Dilution
-33.83%-76.24%-12.70%-0.19%-25.24%-22.97%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.